Maureen Rutten-van Molken
- Cost-effectiveness of tiotropium versus salmeterol: A trial-based analysis followed by a model-based extrapolationBy Martine Hoogendoorn, Maiwenn Al, J.-Matthias Graf von der Schulenburg, David Bowles, Brigitta Monz, Hendrik Schmidt, Juliane Lungershausen and Maureen Rutten-van MolkenMartine Hoogendoorn1Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, NetherlandsMaiwenn Al1Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, NetherlandsJ.-Matthias Graf von der Schulenburg2School of Economics and Management, Leibniz University Hanover, Hanover, GermanyDavid Bowles3Faculty of Health Sciences, University of Bielefeld, Bielefeld, GermanyBrigitta Monz4Boehringer Ingelheim, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyHendrik Schmidt4Boehringer Ingelheim, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyJuliane Lungershausen4Boehringer Ingelheim, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyMaureen Rutten-van Molken1Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, Netherlands
- Comparing the cost-effectiveness of a wide range of COPD interventions using a stochastic population model for COPDBy Martine Hoogendoorn, Maureen Rutten-van Mölken, Rudolf Hoogenveen, Maiwenn Al and Talitha FeenstraMartine Hoogendoorn1Institute for Medical Technology Assessment (iMTA), Erasmus University, Rotterdam, NetherlandsMaureen Rutten-van Mölken1Institute for Medical Technology Assessment (iMTA), Erasmus University, Rotterdam, NetherlandsRudolf Hoogenveen2Expertise Centre for Methodology and Information Service, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsMaiwenn Al1Institute for Medical Technology Assessment (iMTA), Erasmus University, Rotterdam, Netherlands
- Are disease management programs for COPD cost-effective?By Melinde Boland, Apostolos Tsiachristas, Annemarije Kruis, Niels Chavannes and Maureen Rutten-van MölkenMelinde Boland1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsApostolos Tsiachristas1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsAnnemarije Kruis2Public Health and Primary Care, Leiden University Medical Center, Leiden, NetherlandsNiels Chavannes2Public Health and Primary Care, Leiden University Medical Center, Leiden, NetherlandsMaureen Rutten-van Mölken1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, Netherlands
- Cost-effectiveness of early assisted discharge for COPD exacerbations in the NetherlandsBy Lucas Goossens, Cecile Utens, Frank Smeenk, Onno van Schayck and Maureen Rutten-van MölkenLucas Goossens1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsCecile Utens2CAPHRI, Maastricht University, Maastricht, NetherlandsFrank Smeenk3Pulmonary Disease, Catharina Hospital, Eindhoven, NetherlandsOnno van Schayck2CAPHRI, Maastricht University, Maastricht, NetherlandsMaureen Rutten-van Mölken1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, Netherlands
- Compliance and persistence among users of subcutaneous and sublingual allergen immunotherapyBy Menno Kiel, Esther Röder, Wim Hop, Maiwenn Al, Roy Gerth van Wijk and Maureen Rutten-van MölkenMenno Kiel1Dept. of Health Economics, Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsEsther Röder2Section of Allergology, ErasmusMC-University Medical Centre, Rotterdam, NetherlandsWim Hop3Department of Epidemiology & Biostatistics, ErasmusMC-University Medical Centre, Rotterdam, NetherlandsMaiwenn Al1Dept. of Health Economics, Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsRoy Gerth van Wijk2Section of Allergology, ErasmusMC-University Medical Centre, Rotterdam, NetherlandsMaureen Rutten-van Mölken1Dept. of Health Economics, Institute for Medical Technology Assessment, Erasmus University, Rotterdam, Netherlands
- Inpatient hospital care or hospital-at-home for COPD exacerbations: A discrete choice experimentBy Lucas Goossens, Cecile Utens, Frank Smeenk, Bas Donkers, Onno van Schayck and Maureen Rutten-van MölkenLucas Goossens1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsCecile Utens2CAPHRI, Maastricht University, Maastricht, NetherlandsFrank Smeenk3Pulmonary Disease, Catharina Hospital, Eindhoven, NetherlandsBas Donkers4Erasmus School of Economics, Erasmus University, Rotterdam, NetherlandsOnno van Schayck2CAPHRI, Maastricht University, Maastricht, NetherlandsMaureen Rutten-van Mölken1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, Netherlands
- The effectiveness of integrated disease management (IDM) programmes for COPD patients: A Cochrane systematic reviewBy Annemarije Kruis, Nynke Smidt, Pim Assendelft, Jacobijn Gussekloo, Melinde Boland, Maureen Rutten-van Molken and Niels ChavannesAnnemarije Kruis1Department of Public Health and Primary Care, Leiden University Medical Center, Lumc, NetherlandsNynke Smidt2Department of Epidemiology, University Medical Center Groningen, Groningen, NetherlandsPim Assendelft3Department of Primary Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, NetherlandsJacobijn Gussekloo1Department of Public Health and Primary Care, Leiden University Medical Center, Lumc, NetherlandsMelinde Boland4Institute of Health Care Policy and Management/Institute of Medical Technology, Erasmus University Rotterdam, Rotterdam, NetherlandsMaureen Rutten-van Molken4Institute of Health Care Policy and Management/Institute of Medical Technology, Erasmus University Rotterdam, Rotterdam, NetherlandsNiels Chavannes1Department of Public Health and Primary Care, Leiden University Medical Center, Lumc, Netherlands
- Current and future costs of COPD in the NetherlandsBy Anita Suijkerbuijk, Rudolf Hoogenveen, Ardine De Wit, Alet Wijga, Martine Hoogendoorn, Maureen Rutten-van Mölken and Talitha FeenstraAnita Suijkerbuijk1Prevention and Health Services Research, RIVM, Bilthoven, NetherlandsRudolf Hoogenveen1Prevention and Health Services Research, RIVM, Bilthoven, NetherlandsArdine De Wit1Prevention and Health Services Research, RIVM, Bilthoven, NetherlandsAlet Wijga1Prevention and Health Services Research, RIVM, Bilthoven, NetherlandsMartine Hoogendoorn2iMTA, Erasmus University Rotterdam, Rotterdam, NetherlandsMaureen Rutten-van Mölken1Prevention and Health Services Research, RIVM, Bilthoven, NetherlandsTalitha Feenstra1Prevention and Health Services Research, RIVM, Bilthoven, Netherlands
- Nutritional assessment and therapy in COPD: a European Respiratory Society statementBy Annemie M. Schols, Ivone M. Ferreira, Frits M. Franssen, Harry R. Gosker, Wim Janssens, Maurizio Muscaritoli, Christophe Pison, Maureen Rutten-van Mölken, Frode Slinde, Michael C. Steiner, Ruzena Tkacova and Sally J. SinghArticle | Published in 2014 in European Respiratory JournalAnnemie M. Schols1NUTRIM School for Nutrition, Toxicology and Metabolism, Dept of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The NetherlandsIvone M. Ferreira2Asthma and Airways Centre, Toronto Western Hospital, Toronto, Canada3Dept of Respiratory Medicine, McMaster University, Hamilton, CanadaFrits M. Franssen4Program Development Centre, CIRO+ (Centre of Expertise for Chronic Organ Failure), Horn, The NetherlandsHarry R. Gosker1NUTRIM School for Nutrition, Toxicology and Metabolism, Dept of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The NetherlandsWim Janssens5Laboratory of Respiratory Medicine, Katholieke Universiteit, Leuven, BelgiumMaurizio Muscaritoli6Dept of Clinical Medicine, Sapienza University of Rome, Rome, ItalyChristophe Pison7Clinique Universitaire de Pneumologie, Institut du Thorax, CHU Grenoble, Grenoble, France8Inserm U1055, Grenoble, France9Université Joseph Fourier, Grenoble, France10European Institute for Systems Biology and Medicine, Lyon, FranceMaureen Rutten-van Mölken11Erasmus University Rotterdam, Institute of Health Policy and Management, Rotterdam The Netherlands12Erasmus University Rotterdam, Institute of Medical Technology Assessment, Rotterdam, The NetherlandsFrode Slinde13Dept of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy at University of Gothenburg, Gothenburg, SwedenMichael C. Steiner14Centre for Exercise and Rehabilitation Science, Leicester Respiratory Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UKRuzena Tkacova15Dept of Respiratory Medicine, Faculty of Medicine, P.J. Safarik University, Kosice, Slovakia16L. Pasteur University Hospital, Kosice, SlovakiaSally J. Singh14Centre for Exercise and Rehabilitation Science, Leicester Respiratory Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK
- Nutritional assessment and therapy in COPD: a European Respiratory Society statementBy Annemie M. Schols, Ivone M. Ferreira, Frits M. Franssen, Harry R. Gosker, Wim Janssens, Maurizio Muscaritoli, Christophe Pison, Maureen Rutten-van Mölken, Frode Slinde, Michael C. Steiner, Ruzena Tkacova and Sally J. SinghAnnemie M. Schols1NUTRIM School for Nutrition, Toxicology and Metabolism, Dept of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The NetherlandsIvone M. Ferreira2Asthma and Airways Centre, Toronto Western Hospital, Toronto, Canada3Dept of Respiratory Medicine, McMaster University, Hamilton, CanadaFrits M. Franssen4Program Development Centre, CIRO+ (Centre of Expertise for Chronic Organ Failure), Horn, The NetherlandsHarry R. Gosker1NUTRIM School for Nutrition, Toxicology and Metabolism, Dept of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The NetherlandsWim Janssens5Laboratory of Respiratory Medicine, Katholieke Universiteit, Leuven, BelgiumMaurizio Muscaritoli6Dept of Clinical Medicine, Sapienza University of Rome, Rome, ItalyChristophe Pison7Clinique Universitaire de Pneumologie, Institut du Thorax, CHU Grenoble, Grenoble, France8Inserm U1055, Grenoble, France9Université Joseph Fourier, Grenoble, France10European Institute for Systems Biology and Medicine, Lyon, FranceMaureen Rutten-van Mölken11Erasmus University Rotterdam, Institute of Health Policy and Management, Rotterdam The Netherlands12Erasmus University Rotterdam, Institute of Medical Technology Assessment, Rotterdam, The NetherlandsFrode Slinde13Dept of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy at University of Gothenburg, Gothenburg, SwedenMichael C. Steiner14Centre for Exercise and Rehabilitation Science, Leicester Respiratory Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UKRuzena Tkacova15Dept of Respiratory Medicine, Faculty of Medicine, P.J. Safarik University, Kosice, Slovakia16L. Pasteur University Hospital, Kosice, SlovakiaSally J. Singh14Centre for Exercise and Rehabilitation Science, Leicester Respiratory Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK
- Cost-effectiveness of an integrated care program for COPD: The RECODE cluster randomized trialBy Melinde Boland, Annemarije Kruis, Apostolos Tsiachristas, Willem Assendelft, Jacobijn Gusselkoo, Coert Blom, Niels Chavannes and Maureen Rutten-van MolkenMelinde Boland1Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, NetherlandsAnnemarije Kruis2Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, NetherlandsApostolos Tsiachristas1Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, NetherlandsWillem Assendelft3Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, NetherlandsJacobijn Gusselkoo2Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, NetherlandsCoert Blom4Stichting Zorgdraad, Stichting Zorgdraad Foundation, Oosterbeek, NetherlandsNiels Chavannes2Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, NetherlandsMaureen Rutten-van Molken1Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, Netherlands
- Is integrated disease management of COPD effective? Results of the RECODE cluster randomized controlled trial in real world patientsBy Annemarije Kruis, Melinde Boland, Willem Assendelft, Jacobijn Gussekloo, Apostolos Tsiachristas, Theo Stijnen, Coert Blom, Jacob Sont, Maureen Rutten-van Molken and Niels ChavannesAnnemarije Kruis1Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, NetherlandsMelinde Boland2Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsWillem Assendelft1Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, Netherlands3Department of Primary and Community Care, Radboud University Nijmegen Medical Center, Nijmegen, NetherlandsJacobijn Gussekloo1Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, NetherlandsApostolos Tsiachristas2Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsTheo Stijnen4Department of Medical Statistics and Bioinformatics, Leiden University Medical Centre, Leiden, NetherlandsCoert Blom5Stichting Zorgdraad Foundation, Stichting Zorgdraad, Oosterbeek, NetherlandsJacob Sont6Department of Medical Decision Making, Leiden University Medical Centre, Leiden, NetherlandsMaureen Rutten-van Molken2Institute for Medical Technology Assessment, Erasmus University, Rotterdam, NetherlandsNiels Chavannes1Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, Netherlands
- E-monitoring of asthma therapy to improve compliance in children (E-MATIC)By Erwin Vasbinder, Lucas Goossens, Hettie Janssens, Brenda De Winter, Liset Van Dijk, Arnold Vulto, Maureen Rutten-van Mölken and Patricia Van den BemtErwin Vasbinder1Hospital Pharmacy, Erasmus Medical Center, Rotterdam, NetherlandsLucas Goossens2Institute of Health Care Policy and Management/Institute of Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, NetherlandsHettie Janssens3Pediatric Respiratory Medicine, Erasmus Medical Center, Rotterdam, NetherlandsBrenda De Winter1Hospital Pharmacy, Erasmus Medical Center, Rotterdam, NetherlandsLiset Van Dijk4NIVEL, NIVEL, Utrecht, NetherlandsArnold Vulto1Hospital Pharmacy, Erasmus Medical Center, Rotterdam, NetherlandsMaureen Rutten-van Mölken2Institute of Health Care Policy and Management/Institute of Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, NetherlandsPatricia Van den Bemt1Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands
- Does registration of performance indicators improve health outcomes in COPD?By Melinde Boland, Apostolos Tsiachristas, Niels Chavannes and Maureen Rutten-van MölkenMelinde Boland1Institute for Medical Technology Assessment, Institute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, NetherlandsApostolos Tsiachristas1Institute for Medical Technology Assessment, Institute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands2Health Economics Research Centre, Department of Population Health, University of Oxford, Oxford, United KingdomNiels Chavannes3Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, NetherlandsMaureen Rutten-van Mölken1Institute for Medical Technology Assessment, Institute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.